Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been assigned an average recommendation of “Hold” from the nine brokerages that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $21.56.

Several equities research analysts recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target on the stock. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. Finally, UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective on the stock.

Insider Activity

In related news, COO Steven Wolin sold 19,580 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $354,006.40. Following the transaction, the chief operating officer now owns 102,598 shares of the company’s stock, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the sale, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. State Street Corp raised its position in Oscar Health by 6.0% during the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after acquiring an additional 455,205 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Oscar Health by 20.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after acquiring an additional 270,223 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in Oscar Health by 161.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after purchasing an additional 860,226 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Down 1.5 %

Shares of OSCR stock opened at $13.40 on Wednesday. The company’s fifty day simple moving average is $15.81 and its two-hundred day simple moving average is $17.35. Oscar Health has a 52 week low of $8.44 and a 52 week high of $23.79. The stock has a market cap of $3.31 billion, a P/E ratio of -223.30 and a beta of 1.63. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same quarter in the prior year, the firm posted ($0.29) earnings per share. Oscar Health’s quarterly revenue was up 68.3% on a year-over-year basis. Analysts predict that Oscar Health will post -0.01 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.